MAPT and Alzheimer disease: Thus, it has been hypothesised that neuronal exposure to Aβ during early phases of preclinical AD might be reflected on the gradual appearance of different p‐tau species in CSF (preprint: Ashton et al, 2021a; Ashton et al, 2021b).